Quality in Endoscopy and Cost Effective Practice

Similar documents
Advanced Imaging and the Colon- Which Technology Should I Adopt?

Tips to Improve ADRs during Colonoscopy

Improving you ADR. Robert Enns Colonoscopy Education Day October 2018

Technology and Interventions to Improve ADR

Improving Your Adenoma Detection Rate

Improving the Adenoma Detection Rate. ADR is a (the) priority quality indicator

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection

Performance targets for lesion detection in surveillance

Finding and Removing Difficult Polyps (safely)

Carol A. Burke, MD, FACG

Colon Polyps: Detection, Inspection and Characteristics

Missed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand

Devices To Improve Colon Polyp Detection

Interval Cancers: What is Next?

WEO CRC SC Meeting. Barcelona, Spain October 23, 2015

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Prof Rupert Leong, Director of Endoscopy, Head of IBD Professor of Medicine UNSW, University of Sydney, Concord Hospital Australia IBDSydney

Post-colonoscopy colorectal cancers in Lynch syndrome

Colorectal Cancer Screening and Surveillance

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

Difficult Polypectomy 2015 Tool of the Trade

Quality in Endoscopy: Can We Do Better?

Post-polypectomy follow-up after. removal of colorectal neoplasia

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Hamideh Salimzadeh, PhD Assistant Professor, Digestive Diseases Research Center,Tehran University of Medical Sciences, Shariati Hospital, North

ADR AT A GLANCE. Facts to Know about the Adenoma Detection Rate

Quality indicators for colonoscopy and colonoscopist. Mirjana Kalauz Clinical Hospital Center Zagreb

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Dysplasia 4/19/2017. How do I practice Chromoendoscopy for Surveillance of Colitis? SCENIC: Polypoid Dysplasia in UC. Background

Quality Measures In Colonoscopy: Why Should I Care?

Digestive Health Southwest Endoscopy 2016 Quality Report

Colonoscopy Quality Data

The Natural History of Right-Sided Lesions

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD

Management of Barrett s: From Imaging to Resection

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

Noninvasive Molecular Detection of Colorectal Neoplasia

Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies

Quality of and compliance with colonoscopy in Lynch Syndrome surveillance: are we getting it right?

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Colorectal Cancer: Screening & Surveillance

Experience and challenges of implementing optical diagnosis into clinical practice UK and European Perspective

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it

Colorectal Cancer Screening

Polyp detection rates as quality indicator in clinical versus screening colonoscopy

GI Screening/Surveillance in Lynch Syndrome

Colon Cancer Screening Trends. U.S. Cancer Stastistics 2010

Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center

Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases

BENEFIT APPLICATION BLUE CARD/NATIONAL ACCOUNT ISSUES

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

Chromoendoscopy - Should It Be Standard of Care in IBD?

COLON: Innovations 3 steps, 3 parts..

Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN

How to characterize dysplastic lesions in IBD?

Learning Objectives:

Kathy P. Bull-Henry, MD, FACG Dr. Bull-Henry has indicated no relevant financial relationships. Don t Waste Time With No Chance to See

PQRS/QCDR/VBPM/GIQuIC -- Making $ense of All the Letters

Chromoendoscopy and Endomicroscopy for detecting colonic dysplasia

ACG Clinical Guideline: Colorectal Cancer Screening

Measuring the quality of colonoscopy: Where are we now and where are we going?

Bowel screening cancer prevention

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

Colorectal Cancer Screening: A Clinical Update

Management of pt1 polyps. Maria Pellise

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Number of polyps detected is a useful indicator of quality of clinical colonoscopy

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals

Gregory G. Ginsberg, M.D.

With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention

Predict, Resect and discard : Yes we can! (at least in some hands)

THE EFFECT OF PUBLIC AND PHYSICIAN EDUCATION ON COMMUNITY COLORECTAL CANCER SCREENING. Michael D Sarap MD, FACS Ohio CoC Co Chair

Colonoscopy performance is stable during the course of an extended three-session working day

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program

Research & Teaching AWARDS. Morris F. Collen Research Awards Teaching Awards for Excellence

Do any benign polyps require an operation?

Advances in diagnostic and therapeutic colonoscopy

Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate?

Chromoendoscopy as an Adjunct to Colonoscopy

Colonoscopy Quality Assessment

Colon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4

Bowel Screening Colonoscopy in Glasgow How well are we doing? How well should we be doing? How can we evidence and improve performance?

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Corporate Medical Policy

Colorectal cancer screening A puzzle of tests and strategies

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Trends in quality of screening colonoscopy in Austria

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications

효과적인대장정결법 김태준 삼성서울병원소화기내과

Neoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Barrett's Esophagus: Sorting Out the Controversy

An Updated Approach to Colon Cancer Screening and Prevention

Transcription:

Quality in Endoscopy and Cost Effective Practice Sunanda Kane, MD MSPH FACG Director, ACG Quality Council 1

What is Quality and/or Cost Effectiveness in an Endoscopic Practice? Value Equation Quality (Outcomes, Safety, Service) Cost (price x use rate) Increasing Value Increase Quality Improve outcomes Improve safety/decrease harm Increase service Decrease cost Bundling Efficiency changes 2

Quality Indicators for Colonoscopy Current ADR Appropriate use of surveillance/screening intervals Cecal intubation rates Future Adequacy of Bowel Prep Adequacy of polypectomy ADR-plus Periprocedural management of antiplatelet and anticoagulant drugs Rate of interval cancers Rate of lost specimens Rate of surgical referrals Recognition of sessile serrated lesions Fundamental of High Quality Colonoscopy Careful inspection At least 6-8 minutes Looking behind folds Attentive to flat mucosal changes Proper documentation Prep quality Patient acceptance and compliance 3

How Can We Improve Colonoscopy Quality Mandate longer withdrawal time? Education/Attention to good methods? Washing, look behind folds Advanced Imaging methods? Improved bowel prep? Improve acceptance? What s the Problem? 10 fold Variation In ADR Barclay et al. NEJM;2006;355:2533 4

High ADR Reduces Interval Cancers Corley Kaiser study DDW 2013, ADR associated with interval CA Kaminski et al. NEJM;2010;362:1795 Mandated Withdrawal Time and Adenoma Detection Mandating longer WD time does not increase ADR Sawhaney Gastro 2008;135;1892 Compliance w/ mandate ADR after Mandate 5

Notification (personal and public) Does Not Increase ADR Group ADR presented (blinded) Indiv. ADR presented (private) Indiv. ADR presented (public) Indiv. 1:1 meeting w/ chair Shaukat et al. CGH 2009;7:1335 Mayo Endoscopic Quality Improvement Project (EQUIP study) Randomized, single blind, education intervention Focus on Adenoma Detection Rate 2 Educational sessions (1-1.5 hrs each) Techniques to improve detection (with videos) Videos of highest ADR doctors Monthly feedback on ADR and WD time Results posted on ASC wall (de-identified) Individual informed of ADR and group data Measured ADR baseline (3 months, 1200 cases) Repeat after intervention (1200 cases) Coe et al. Am J Gastro 2013;108:219 6

Effect of EQUIP Training 36% 36% 36% 47% P<0.01 ADR by adenoma size and study phase (Trained group) Detection Rate* 40% 30% 20% 10% 0% 1-5 6-9 10+ Adenoma size Phase I Phase II 7

Detection Rate e* 50% 0% ADR by adenoma shape (Trained group) Polypoid Non- polypoid Adenoma shape Phase I Phase II Withdrawal time Did not change with intervention ti Untrained group 8 min (6-11) Phase I 9 min (6-12) Phase II Trained group 10 min (8-13) Phase I 11 min (9-14) Phase II 8

ADR Increase Was Durable (in fact continued to increase) Beyond Study 65% ADR 55% 45% 35% 25% 36% 47% 35% 46% 39% Untrained Trained 15% Phase 1 Phase 2 Phase 3 Summary Adenoma Detection can be improved by education Variable results Focus on Withdrawal time does not change ADR Passive Notification does not change ADR Active education + public/private notification durably increases ADR Create a Culture of Quality Focus on ADR alone has potential for gaming 9

How Can We Improve Colonoscopy Quality Mandate longer withdrawal time? Education/Attention to good methods? Washing, look behind folds Advanced Imaging methods? Improved bowel prep? Improve acceptance? High Definition Colonoscopy: A Meta-Analysis Study N (std def) N (HD) ADR (total) East 2008 72 58 65% Pellise 2008 310 310 26% Burke 2010 426 426 23% Buchner 2010 1226 1204 27% Tribonias 2009 197 193 54% Net effect of HD 3.5% 35%[09 [0.9-6.1] increase in all ADR -0.1% [-1.7-1.6] for advanced ADR Adapted from Subramanian et al Endoscopy 2011;43:499 10

NBI Does Not Increase Adenoma Detection Meta Analysis: 6 Randomized Trials Dinesen, GIE, 2012;75:604-11 How Can We Improve Colonoscopy Quality Mandate longer withdrawal time? Education/Attention to good methods? Washing, look behind folds Advanced Imaging methods? Improved bowel prep? Improve acceptance? 11

Split Dose: Better Prep, Better Tolerated Bowel Prep Quality Patient Willingness to Repeat Same Prep Kilgore et al. GIE 2011;73:1240 Poor Prep Quality: It Will be our Fault! I have bad patients won t cut it Split dosing acceptable to patients t Smartphone Apps available to help patients through the process Free app download at itunes store https://itunes.apple.com/us/app/adh/id568 880917?mt=8&Is=1 Recent RCT on LR diet comparable to clear liquids the day before colonoscopy (Stolpman D et al DDW 2013) 12

Summary Good technique is paramount Looking behind folds Slow withdrawal Looking for flat mucosal change Technology helps but no substitute ADR is well validated measure of quality CAN be improved and maintained in practice PDR is reasonable surrogate PDR 30% correlated with ADR 20% In practice, we audit if PDR < 40% Both have potential for gaming Split dose prep improves quality and tolerance 13